open access

Vol 4 (2019): Continuous Publishing
ORIGINAL PAPERS
Published online: 2019-05-21
Get Citation

The prevalence of HBV, HCV, and HIV infections in patients with cataract in Turkey

Mehmet Cubuk, Oguz Guvenmez, Bahadır Özelbaykal
DOI: 10.5603/OJ.2018.0038
·
Ophthalmol J 2019;4:7-10.

open access

Vol 4 (2019): Continuous Publishing
ORIGINAL PAPERS
Published online: 2019-05-21

Abstract

Background: Hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) cause common
infections all around the world. The aim of this study is to determine the HBV, HCV, and HIV prevalence in
cataract patients.

Material and methods: This was a retrospective study and was carried out in the ophthalmology clinic of Adana
Numune Research and Training Hospital (Adana, Turkey). One hundred and forty patients undergoing cataract
surgery were included to the study. The clinical findings were extracted from the medical records of the patients.
The serological analyzing was done by one step immunoassay-based rapid diagnostic card tests for hepatitis B surface
antigen (HBsAg), anti-HCV, and anti-HIV antibodies. HBV and HCV confirmations were done by ELISA (enzyme-linked immunosorbent assay test)-based serological tests.

Results: Of the 1040 patients included in the study, 462 (44.4%) were females and 578 (55.6%) were males.
The mean age of the patients was 64.8 ± 13.7 years. HBsAg was positive in 39 (3.8%) patients and Anti-HCV was
positive in 14 (1.3%) patients. None of the patients had HIV.

Conclusion: HBV is the most common infection among cataract patients and it is very important to apply infection
prevention methods.

Abstract

Background: Hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) cause common
infections all around the world. The aim of this study is to determine the HBV, HCV, and HIV prevalence in
cataract patients.

Material and methods: This was a retrospective study and was carried out in the ophthalmology clinic of Adana
Numune Research and Training Hospital (Adana, Turkey). One hundred and forty patients undergoing cataract
surgery were included to the study. The clinical findings were extracted from the medical records of the patients.
The serological analyzing was done by one step immunoassay-based rapid diagnostic card tests for hepatitis B surface
antigen (HBsAg), anti-HCV, and anti-HIV antibodies. HBV and HCV confirmations were done by ELISA (enzyme-linked immunosorbent assay test)-based serological tests.

Results: Of the 1040 patients included in the study, 462 (44.4%) were females and 578 (55.6%) were males.
The mean age of the patients was 64.8 ± 13.7 years. HBsAg was positive in 39 (3.8%) patients and Anti-HCV was
positive in 14 (1.3%) patients. None of the patients had HIV.

Conclusion: HBV is the most common infection among cataract patients and it is very important to apply infection
prevention methods.

Get Citation

Keywords

HBV; HCV; HIV; prevalence; cataract

About this article
Title

The prevalence of HBV, HCV, and HIV infections in patients with cataract in Turkey

Journal

Ophthalmology Journal

Issue

Vol 4 (2019): Continuous Publishing

Pages

7-10

Published online

2019-05-21

DOI

10.5603/OJ.2018.0038

Bibliographic record

Ophthalmol J 2019;4:7-10.

Keywords

HBV
HCV
HIV
prevalence
cataract

Authors

Mehmet Cubuk
Oguz Guvenmez
Bahadır Özelbaykal

References (15)
  1. Scardino PT. A hazard surgeons need to address. Nat Clin Pract Urol. 2007; 4(7): 347.
  2. Curry MP, Chopra S. Acute Viral Hepatitis. In: Mandell GL, Bennett JE, Dolin R. ed. Principles and Practice of Infectious Disease. 6th ed. Churchill Livingstone, Philadelphia 2005: 1426–1441.
  3. Sünbül M. Enfeksiyonunun Epidemiyolojisi ve Korunma. In: Tabak F, Balık İ, Tekeli E. ed. Viral Hepatit’2007. Viral Hepatitle Savaşım Derneği, Istanbul 2006: 208.
  4. Girgin S, Temiz H, Gedik E, et al. Genel cerrahi hastalarında preoperatif HBsAg, Anti-HCV, Anti-HIV seroprevalansı. Dicle Tıp Derg. ; 2009: 283–287.
  5. World Health Organization. Hepatitis B Surface Antigen Assays: Operational Characteristics. http://www who int/diagnostics_laboratory/evaluations/en/hep_B_rep1 pdf.
  6. World Health Organization. Hepatitis C Assays: Operational Characteristics . http://www who int/iris/bitstream/10665/66829/1/WHO_BCT_BTS_01.
  7. World Health Organization. HIV Assays, Laboratory performance and other operational characteristics. http://www.who.int/diagnostics_laboratory/publications/15032_hiv_assay_report18.pdf?ua=1.
  8. National Guidelines for HIV Testing. Published by National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India 2015: 40.
  9. Tahir MA, Cheema A, Tareen S. Frequency of Hepatitis-B and C in patients undergoing cataract surgery in a tertiary care Centre. Pak J Med Sci. 2015; 31(4): 895–898.
  10. Ambastha A, Kusumesh R, Bhasker G. Why Should Viral Markers Be Mandatory in Ocular Surgeries: A Hospital Based Retrospective Study. J Clin Diagn Res. 2016; 10(10): LC09–LC11.
  11. Naeem SS, Siddiqui EU, Kazi AN, et al. Prevalence of hepatitis 'B' and hepatitis 'C' among preoperative cataract patients in Karachi. BMC Res Notes. 2012; 5: 492.
  12. Lohano MK, Su L, Narsani AK, et al. Frequency of hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCVAb) seropositivity among preoperative eye surgery patients. BJMP. 2016; 9(2): a918.
  13. Demir T, Yenice MG, Sarıkaya K. Ürolojik Cerrahiye Alınacak Hastalarda Operasyon Öncesi HBs-Ag, Anti-HCV ve Anti-HIV Pozitiflik Oranlarının Değerlendirilmesi. Selçuk Üniv Tıp Derg. 2011; 27(4): 201–4.
  14. Özdemir D, Kurt H. Hepatit B Virusu Enfeksiyonlarının Epidemiyolojisi. In: Tabak F, Balık İ, Tekeli E. ed. Viral Hepa-tit’2007. Viral Hepatitle Savaşım Derneği, Istanbul 2006: 108–116.
  15. Hosoglu S, Akalin S, Sunbul M, et al. Occupational Infections Study Group. Predictive factors for occupational bloodborne exposure in Turkish hospitals. Am J Infect Control. 2009; 37(1): 65–69.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl